Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care

Abstract

Survival for pediatric patients diagnosed with cancer has improved significantly. This achievement has been made possible due to new treatment modalities and the incorporation of a systematic multidisciplinary approach for supportive care. Understanding the distinctive cardiovascular characteristics of children undergoing cancer therapies has set the underpinnings to provide comprehensive care before, during, and after the management of cancer. Nonetheless, we acknowledge the challenge to understand the rapid expansion of oncology disciplines. The limited guidelines in pediatric cardio-oncology have motivated us to develop risk-stratification systems to institute surveillance and therapeutic support for this patient population. Here, we describe a collaborative approach to provide wide-ranging cardiovascular care to children and young adults with oncology diseases. Promoting collaboration in pediatric cardio-oncology medicine will ultimately provide excellent quality of care for future generations of patients.

Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021

“…An example discussed was the Childhood Cancer Survivor Cardiovascular Risk Calculator . Understanding the unique cardiovascular characteristics of children undergoing cancer therapies has paved the way for comprehensive care prior to, during, and after cancer treatment [ 21 ]. Survival rates for pediatric cancer patients have significantly increased.…”

Identifying Hypoxia and Glycolysis in Chemotherapy- and Radiation-Induced Cardiotoxicity by Nuclear Medicine Diagnostic Imaging With 18F-Flurodeoxyglucose – Key Role of Coenzyme Q10 Deficiency in Acquired Mitochondrial Dysfunction

“…Belger and coworkers analyzed risk factors in relation to cardiotoxicity and concluded inconclusively that "a better understanding" would be desirable [15]. The same applies to surveillance programs based on epidemiological data [16,17]. Epidemiology alone, cannot deliver treatment options.…”

Connected Health Innovation Research Program (C.H.I.R.P.): A bridge for digital health and wellness in cardiology and oncology

“…Cancer therapies are evolving rapidly to improve outcomes for cancer survivors, but many of these therapies associate with cardiovascular toxicities [ 4 ]. Thus, the new medical subspecialty cardio-oncology has emerged to address the prevention, monitoring, and management of cardiovascular toxicities related to cancer therapies [ 5 , 6 ]. Yet, studies indicate that cancer survivors may not be receiving optimal monitoring for cardiovascular health and wellness [ 7 , 8 ].…”